MoneyWorks4Me

Cadila Healthcare to exit from its business in Japan

27 Jan 2014 Evaluate

Cadila Healthcare has decided to exit from its business in Japan, which is through 100% subsidiary Company after completing portfolio and strategy review of its business.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..